Hypera Pharma (HYPE3)
BOV
Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | BRL (R$) | |
Total Assets | 11.49B | 10.13B | 10.56B | 11.92B | 17.25B | 19.82B | 23.76B | 24.51B |
Total Current Assets | 5.35B | 3.93B | 4.32B | 4.74B | 7.9B | 6.49B | 8.53B | 8.08B |
Cash and Equivalents | 23.52M | 9.72M | 14.57M | 2.25B | 4.74B | 2.29B | 2.86B | 2.58B |
Total Non-Current Assets | 8.81B | 7.74B | 8.27B | 8.71B | 9.24B | 9.83B | 10.66B | 11.52B |
Total Liabilities | 2.67B | 2.39B | 2.29B | 3.21B | 8.01B | 9.98B | 13.1B | 12.99B |
Total Current Liabilities | 1.74B | 1.71B | 1.42B | 1.59B | 2.63B | 2.78B | 5.23B | 4.64B |
Total Non-Current Liabilities | 1.62B | 1B | 1.33B | 2.92B | 10.43B | 14B | 15.25B | 16.16B |
Total Equity | 8.81B | 7.74B | 8.27B | 8.71B | 9.24B | 9.83B | 10.66B | 11.52B |
Common Equity | 5.27B | 4.45B | 4.45B | 4.45B | 4.48B | 4.48B | 4.48B | 4.48B |
Retained Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.